These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36787450)
1. Prediction of Metabolic Syndrome in U.S. Adults Using Homeostasis Model Assessment-Insulin Resistance. Guess J; Beltran TH; Choi YS Metab Syndr Relat Disord; 2023 Apr; 21(3):156-162. PubMed ID: 36787450 [No Abstract] [Full Text] [Related]
2. Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis. Wan H; Cao H; Ning P Sci Rep; 2024 Jul; 14(1):15499. PubMed ID: 38969755 [TBL] [Abstract][Full Text] [Related]
3. Association of insulin resistance indicators with hepatic steatosis and fibrosis in patients with metabolic syndrome. Kuo TC; Lu YB; Yang CL; Wang B; Chen LX; Su CP BMC Gastroenterol; 2024 Jan; 24(1):26. PubMed ID: 38195414 [TBL] [Abstract][Full Text] [Related]
4. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults. Seo YG; Song HJ; Song YR J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):710-725. PubMed ID: 32030917 [TBL] [Abstract][Full Text] [Related]
5. METS-IR/HOMA-IR and MAFLD in U.S. adults: dose-response correlation and the effect mediated by physical activity. Peng H; Xiang J; Pan L; Zhao M; Chen B; Huang S; Yao Z; Liu J; Lv W BMC Endocr Disord; 2024 Aug; 24(1):132. PubMed ID: 39085855 [TBL] [Abstract][Full Text] [Related]
6. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Son DH; Lee HS; Lee YJ; Lee JH; Han JH Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):596-604. PubMed ID: 35090800 [TBL] [Abstract][Full Text] [Related]
7. Can Visceral Adiposity Index Serve as a Simple Tool for Identifying Individuals with Insulin Resistance in Daily Clinical Practice? Štěpánek L; Horáková D; Cibičková Ľ; Vaverková H; Karásek D; Nakládalová M; Zapletalová J Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31470593 [No Abstract] [Full Text] [Related]
8. A Single-Point Insulin Sensitivity Estimator (SPISE) of 5.4 is a good predictor of both metabolic syndrome and insulin resistance in adolescents with obesity. Correa-Burrows P; Matamoros M; de Toro V; Zepeda D; Arriaza M; Burrows R Front Endocrinol (Lausanne); 2023; 14():1078949. PubMed ID: 36843603 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Insulin Resistance in the Hungarian General and Roma Populations as Defined by Using Data Generated in a Complex Health (Interview and Examination) Survey. Ádány R; Pikó P; Fiatal S; Kósa Z; Sándor J; Bíró É; Kósa K; Paragh G; Bácsné Bába É; Veres-Balajti I; Bíró K; Varga O; Balázs M Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32635565 [TBL] [Abstract][Full Text] [Related]
10. METS-IR vs. HOMA-AD and Metabolic Syndrome in Obese Adolescents. Widjaja NA; Irawan R; Hanindita MH; Ugrasena I; Handajani R J Med Invest; 2023; 70(1.2):7-16. PubMed ID: 37164746 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the ability of HOMA-IR, VAI, and TyG indexes to predict metabolic syndrome in children with obesity: a cross-sectional study. Dundar C; Terzi O; Arslan HN BMC Pediatr; 2023 Feb; 23(1):74. PubMed ID: 36765298 [TBL] [Abstract][Full Text] [Related]
12. Cutoff values for HOMA-IR associated with metabolic syndrome in the Study of Cardiovascular Risk in Adolescents (ERICA Study). Chissini RBC; Kuschnir MC; de Oliveira CL; Giannini DT; Santos B Nutrition; 2020 Mar; 71():110608. PubMed ID: 31783261 [TBL] [Abstract][Full Text] [Related]
13. Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction. Weinberg AE; Eisenberg M; Patel CJ; Chertow GM; Leppert JT J Sex Med; 2013 Dec; 10(12):3102-9. PubMed ID: 24010555 [TBL] [Abstract][Full Text] [Related]
14. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes. Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148 [TBL] [Abstract][Full Text] [Related]
15. Obesity, metabolic syndrome, and insulin resistance in urban high school students of minority race/ethnicity. Turchiano M; Sweat V; Fierman A; Convit A Arch Pediatr Adolesc Med; 2012 Nov; 166(11):1030-6. PubMed ID: 23007727 [TBL] [Abstract][Full Text] [Related]
16. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score. Gurka MJ; Lilly CL; Oliver MN; DeBoer MD Metabolism; 2014 Feb; 63(2):218-25. PubMed ID: 24290837 [TBL] [Abstract][Full Text] [Related]
17. Homeostasis model assessment of insulin resistance (HOMA-IR) and metabolic syndrome at baseline of a multicentric Brazilian cohort: ELSA-Brasil study. Diniz MFHS; Beleigoli AMR; Schmidt MI; Duncan BB; Ribeiro ALP; Vidigal PG; Benseñor IM; Lotufo PA; Santos IS; Griep RH; Barreto SM Cad Saude Publica; 2020 Sep; 36(8):e00072120. PubMed ID: 32901702 [TBL] [Abstract][Full Text] [Related]
18. Insulin resistance is not necessarily an essential element of metabolic syndrome. Karnchanasorn R; Ou HY; Chuang LM; Chiu KC Endocrine; 2013 Feb; 43(1):92-9. PubMed ID: 22644836 [TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox. Meis SB; Schuster D; Gaillard T; Osei K Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734 [TBL] [Abstract][Full Text] [Related]
20. Proposed cutoff level of waist circumference in Japanese men: evaluation by homeostasis model assessment of insulin resistance levels. Kamezaki F; Sonoda S; Nakata S; Kashiyama K; Muraoka Y; Okazaki M; Tamura M; Abe H; Takeuchi M; Otsuji Y Intern Med; 2012; 51(16):2119-24. PubMed ID: 22892488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]